Contact us to learn more about

our Premium Content: News alerts, weekly reports and conference planners

DRUG:

trastuzumab-IFN-β mutein

Contact us to learn more about our Premium Content:

News alerts, weekly reports and conference planners

Company:

Genopharm

Drug class:

HER2 inhibitor

Related drugs:

‹

trastuzumab biosimilar (0)

trastuzumab biosimilar (0)

trastuzumab (407)

lapatinib (107)

neratinib (102)

trastuzumab-pkrb (24)

margetuximab-cmkb (18)

poziotinib (17)

mobocertinib (12)

trastuzumab-dttb (11)

trastuzumab-strf (9)

trastuzumab-anns (9)

trastuzumab-dkst (9)

trastuzumab-qyyp (9)

Undisclosed allogeneic Vγ9Vδ2 HER2-TAC T (4)

pertuzumab/trastuzumab/hyaluronidase-zzxf (3)

trastuzumab/hyaluronidase-oysk (2)

JBJ-08–178–01 (2)

Hercease (trastuzumab biosimilar) (1)

BAY 2927088 (1)

HERtiCAD (trastuzumab biosimilar) (1)

Hervelous (trastuzumab biosimilar) (1)

EG12014 (trastuzumab biosimilar) (1)

TX05 (trastuzumab biosimilar) (1)

ALT02 (trastuzumab biosimilar) (0)

trastuzumab biosimilar (AP062) (0)

DA 3111 (trastuzumab biosimilar) (0)

HER-2/neu peptide vaccine (0)

HER2 t-haNK (0)

HLX11 (pertuzumab biosimilar) (0)

Hervycta (trastuzumab biosimilar) (0)

JNJ-26483327 (0)

MVA-BN-HER2 (0)

NeuCeptin (trastuzumab biosimilar) (0)

nelipepimut-S (0)

lapuleucel-T (0)

ertumaxomab (0)

trastuzumab biosimilar (SIBP-01) (0)

TAC100-HER2 (0)

glycooptimized trastuzumab-GEX (0)

TrastuRel (trastuzumab biosimilar) (0)

Undisclosed HER2Bi-armed ATC (0)

trastuzumab biosimilar (0)

trastuzumab biosimilar (0)

›

HER-2 positive	Gastric Cancer	HER-2 positive	Gastric Cancer	trastuzumab-IFN-β mutein Sensitive: D – Preclinical trastuzumab-IFN-β mutein Sensitive : D	trastuzumab-IFN-β mutein Sensitive: D – Preclinical trastuzumab-IFN-β mutein Sensitive : D
HER-2 positive	Lung Cancer	HER-2 positive	Lung Cancer	trastuzumab-IFN-β mutein Sensitive: D – Preclinical trastuzumab-IFN-β mutein Sensitive : D	trastuzumab-IFN-β mutein Sensitive: D – Preclinical trastuzumab-IFN-β mutein Sensitive : D
HER-2 positive	HER2 Positive Breast Cancer	HER-2 positive	HER2 Positive Breast Cancer	trastuzumab-IFN-β mutein Sensitive: D – Preclinical trastuzumab-IFN-β mutein Sensitive : D	trastuzumab-IFN-β mutein Sensitive: D – Preclinical trastuzumab-IFN-β mutein Sensitive : D